Press Releases 180 Life Sciences Corp.

Equities

KBLM

US68236V3024

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-29 pm EDT			5-day change	1st Jan Change
1.96 ^USD	+8.89%		+8.89%	-51.68%

Mar. 25	180 Life Sciences Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 11	180 Life Sciences Corp. Announces Board Changes	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

180 Life Sciences : Corporate Presentation	Mar. 14	PU
180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement	Mar. 14	AQ
180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan	Feb. 26	AQ
180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives	Dec. 04	AQ
180 Life Sciences : Material Agreement - Form 8-K	Nov. 29	PU
180 Life Sciences Announces Review of Strategic Alternatives	Nov. 28	AQ
180 Life Sciences : Modification to Rights of Security Holders - Form 8-K	23-09-07	PU
180 Life Sciences Corp. Announces Closing of $3 Million Public Offering	23-08-14	AQ
180 Life Sciences Corp. Announces Pricing of $3 Million Public Offering	23-08-10	AQ
180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral Uptake	23-08-07	AQ
180 Life Sciences Provides Update on Regulatory Approval Process in the UK and US for Dupuytren’s Disease Treatment; Continues Consultations with the UK MHRA and Initiates a Type C Meeting Request With the US FDA	23-08-03	AQ
180 Life Sciences Corp. Announces the Filing of a Provisional Patent Describing the Combination of CBD With GLP-1 Agonists to Suppress Appetite	23-07-31	AQ
180 Life Sciences : Corporate Presentation	23-06-26	PU
180 LIFE SCIENCES CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-04-28	AQ
180 LIFE SCIENCES CORP. : Other Events (form 8-K)	23-04-26	AQ
180 LIFE SCIENCES CORP. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events (form 8-K)	23-04-10	AQ
180 Life Sciences Corp. Announces Closing of $3 Million Registered Direct Offering and Concurrent Private Placement	23-04-10	GL
180 Life Sciences Corp. Announces $3 Million Registered Direct Offering and Concurrent Private Placement	23-04-05	GL
180 LIFE SCIENCES CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	23-03-31	AQ
180 Life Sciences Announces Presentation at the Gordon Conference	23-02-27	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases 180 Life Sciences Corp.

Equities

KBLM

US68236V3024

Press Releases

Filters